KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $10.6 billion.

  • Cvs Health's Cash & Current Investments fell 359.32% to $10.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.6 billion, marking a year-over-year decrease of 359.32%. This contributed to the annual value of $10.6 billion for FY2025, which is 359.32% down from last year.
  • Cvs Health's Cash & Current Investments amounted to $10.6 billion in Q4 2025, which was down 359.32% from $11.2 billion recorded in Q3 2025.
  • Cvs Health's 5-year Cash & Current Investments high stood at $20.0 billion for Q3 2022, and its period low was $8.8 billion during Q1 2021.
  • In the last 5 years, Cvs Health's Cash & Current Investments had a median value of $12.7 billion in 2021 and averaged $13.4 billion.
  • As far as peak fluctuations go, Cvs Health's Cash & Current Investments tumbled by 4202.69% in 2021, and later soared by 5623.35% in 2023.
  • Over the past 5 years, Cvs Health's Cash & Current Investments (Quarter) stood at $12.5 billion in 2021, then increased by 25.53% to $15.7 billion in 2022, then dropped by 27.14% to $11.5 billion in 2023, then fell by 4.03% to $11.0 billion in 2024, then decreased by 3.59% to $10.6 billion in 2025.
  • Its last three reported values are $10.6 billion in Q4 2025, $11.2 billion for Q3 2025, and $14.2 billion during Q2 2025.